Physician

Sreekanth Chandrupatla, M.D.

According to 2025 Medicare claims, Sreekanth Chandrupatla, M.D. (NPI: 1881623767) practices gastroenterology in the Homosassa Springs, FL market, with the plurality of this provider's patient population coming from Citrus, FL. This provider's primary affiliated billing organization is BIKKASANI RAM HELLSTERN AND CHANDRUPATLA MDPA (NPI: 1366651531; TIN: 59-2676843) and primary practice location at 34429-7622.

Chandrupatla's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 992 traditional Medicare patients, billed 4,399 HCPCS/CPT codes, and received $365,692 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 2,251 prescription claims across 919 beneficiaries totaling $1,050,294 in drug costs, led by Creon (Lipase/Protease/Amylase). DME data shows 30 claims. Open Payments data shows 63 records totaling $1,715. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a higher plateau to a lower plateau, from $935,322 to $1,050,294. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,213	10,689	$474,825
2016	1,244	11,169	$480,264
2017	1,218	9,381	$451,027
2018	1,186	8,234	$485,472
2019	1,256	5,813	$448,104
2020	950	4,824	$374,937
2021	1,081	6,273	$436,077
2022	1,050	5,992	$407,090
2023	1,026	4,866	$397,521
2024	992	4,399	$365,692

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	522	1,513	$935,322
2016	551	1,669	$1,535,825
2017	577	1,617	$1,373,136
2018	617	1,560	$667,206
2019	697	1,784	$611,651
2020	600	1,747	$540,332
2021	723	2,094	$607,440
2022	733	2,011	$551,184
2023	839	2,118	$837,223
2024	919	2,251	$1,050,294

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	11	$2,897
2024	N/R	30	$4,526

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	231	232	$214
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	203	215	$78
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	187	187	$72
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	573	934	$66
88305	Pathology examination of tissue using a microscope, intermediate complexity	408	1,035	$55

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Creon	Lipase/Protease/Amylase	43	2,908	$265,112
Ocaliva	Obeticholic Acid	14	420	$134,798
Zenpep	Lipase/Protease/Amylase	12	1,072	$126,257
Xifaxan	Rifaximin	29	678	$83,052
Humira(Cf) Pen	Adalimumab	12	336	$76,589

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4152	Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	15	$3,160
B4034	Enteral feeding supply kit; syringe fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape	N	N/R	15	$1,366

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	63	$1,715	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sreekanth Chandrupatla, M.D.?

Tedicare shows public-source Medicare data for Sreekanth Chandrupatla, M.D. (NPI 1881623767), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sreekanth Chandrupatla, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sreekanth Chandrupatla, M.D.?

Sreekanth Chandrupatla, M.D. is linked to BIKKASANI RAM HELLSTERN AND CHANDRUPATLA MDPA (billing NPI 1366651531) in the available physician profile data.

Does Sreekanth Chandrupatla, M.D. have Open Payments data?

Sreekanth Chandrupatla, M.D. has 63 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.